EQT Life Sciences, formerly LSP, is one of Europe’s largest and most experienced Life Sciences investors, targeting innovative companies focusing on therapeutics, medical devices, diagnostics and healthtech globally. With a track record going back 30 years, EQT Life Sciences has raised around 3.5 billion euros, across 12 private funds and 3 investment strategies.
Access investment thesis, focus areas, bio, and contact details for Arno de Wilde and 22,000+ other VC professionals.
Amsterdam, NL